
|Videos|February 17, 2022
What Pharmacists Should Understand About the Trajectory of the Omicron Variant
Sachin Nagrani, MD, the medical director of Heal, discusses what pharmacists should know about the Omicron variant and other variants popping up globally.
Advertisement
Pharmacy Times interviewed Sachin Nagrani, MD, the medical director of Heal, on Pfizer’s research assessing an Omicron-specific vaccine for adults aged 18 to 55 years.
During the interview, Nagrani discussed what pharmacists should understand about the trajectory of the Omicron variant and whether there are other variants popping up in the world that Americans should be aware of.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Cuts MACE Risk in Diabetes With Heart Disease
2
CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal
3
FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine
4
The Side Door We Could Close: A Pharmacy Perspective on Menopause, Access, and the Leadership Pipeline
5




































































































